Wu J, Levy E M, Black P H
Department of Microbiology, Boston University School of Medicine, MA 02118.
Clin Exp Immunol. 1989 Jul;77(1):7-10.
One contributing factor to the loss of T cells in AIDS may be the impaired ability of T cell precursors to expand, as reflected in a decreased ability of patient cells to form T cell colonies in agar. We and others have noted such a defect in people with AIDS and ARC, and have found that suppressor cells and suppressive plasma contribute to decreased T-CFC formation. We report here that the reducing agents 2-mercaptoethanol (2-ME) and n-acetyl cysteine (NAC) can enhance colony formation in vitro. In part, 2-ME can reverse the defect in T cell colony-forming cells (T-CFC) formation by overcoming the effect of suppressor cells. In a group of 46 AIDS patients, T-CFC formation was initially 42 +/- 8% (mean +/- s.e.) that of control levels. 2-ME caused an increase of 401 +/- 76% in T-CFC formation which was significantly greater than the increase in control T-CFC formation; it also significantly enhanced T-CFC formation by cells from ARC patients. Suppressor cell activity from ten AIDS patients decreased from 58 +/- 21% to 12 +/- 10% when 2-ME was added. Similar data were obtained from 14 ARC patients. NAC, a related antioxidant with low toxicity, also enhanced T-CFC in cells of AIDS and ARC patients. Vitamin C generally did not increase T-CFC formation. The data suggest that certain antioxidants such as 2-ME and NAC may be useful in treatment protocols to enhance T cell numbers in patients with AIDS or ARC.
艾滋病中T细胞丧失的一个促成因素可能是T细胞前体扩增能力受损,这一点体现在患者细胞在琼脂中形成T细胞集落的能力下降。我们和其他人都注意到艾滋病患者和艾滋病相关综合征(ARC)患者存在这样的缺陷,并且发现抑制细胞和抑制性血浆会导致T细胞集落形成细胞(T-CFC)减少。我们在此报告,还原剂2-巯基乙醇(2-ME)和N-乙酰半胱氨酸(NAC)可以增强体外集落形成。部分而言,2-ME可以通过克服抑制细胞的作用来逆转T细胞集落形成细胞(T-CFC)形成的缺陷。在一组46名艾滋病患者中,T-CFC形成最初是对照水平的42±8%(平均值±标准误)。2-ME使T-CFC形成增加了401±76%,这显著高于对照T-CFC形成的增加;它还显著增强了ARC患者细胞的T-CFC形成。当添加2-ME时,十名艾滋病患者的抑制细胞活性从58±21%降至12±10%。从14名ARC患者中也获得了类似的数据。NAC是一种毒性较低的相关抗氧化剂,也增强了艾滋病患者和ARC患者细胞中的T-CFC。维生素C一般不会增加T-CFC形成。数据表明,某些抗氧化剂如2-ME和NAC可能在治疗方案中有用,以增加艾滋病或ARC患者的T细胞数量。